205 related articles for article (PubMed ID: 36000302)
1. Ocular toxicity following carboplatin chemotherapy for neuroendocrine tumour of the bladder.
Ng J; Sadiq M; Mansoor Q
J Oncol Pharm Pract; 2023 Apr; 29(3):768-771. PubMed ID: 36000302
[TBL] [Abstract][Full Text] [Related]
2. Optic neuritis induced by 5-fluorouracil chemotherapy: Case report and review of the literature.
Raina AJ; Gilbar PJ; Grewal GD; Holcombe DJ
J Oncol Pharm Pract; 2020 Mar; 26(2):511-516. PubMed ID: 31735134
[TBL] [Abstract][Full Text] [Related]
3. Blinding Optic Neuropathy Associated With Carboplatin Therapy: A Case Report and Literature Review.
Shihadeh S; Patrick MM; Postma G; Trokthi B; Maitland C
Cureus; 2024 Jan; 16(1):e52975. PubMed ID: 38406141
[TBL] [Abstract][Full Text] [Related]
4. Severe ocular and orbital toxicity after intracarotid injection of carboplatin for recurrent glioblastomas.
Watanabe W; Kuwabara R; Nakahara T; Hamasaki O; Sakamoto I; Okada K; Minamoto A; Mishima HK
Graefes Arch Clin Exp Ophthalmol; 2002 Dec; 240(12):1033-5. PubMed ID: 12483326
[TBL] [Abstract][Full Text] [Related]
5. Risk of Vascular Toxicity with Platinum Based Chemotherapy in Elderly Patients with Bladder Cancer.
Gupta A; Long JB; Chen J; Gross CP; Feldman DR; Steingart RM
J Urol; 2016 Jan; 195(1):33-40. PubMed ID: 26341576
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
[TBL] [Abstract][Full Text] [Related]
7. [How to treat well differentiated endocrine carcinoma with a high proliferative index? A case of gastric endocrine carcinoma].
Stefanescu C; Mathieu N; Bouarioua N; Abbey-Toby A; Karila Cohen P; Chosidow D; Soulé JC; Aparicio T
Gastroenterol Clin Biol; 2006 May; 30(5):798-800. PubMed ID: 16801910
[No Abstract] [Full Text] [Related]
8. Risk-adapted chemotherapy of germ cell tumors with carboplatin, etoposide and bleomycin for low-risk and cisplatin, etoposide and ifosfamide for high-risk patients. A single-center study.
Tscherry G; Jacky E; Jost LM; Stahel RA
Oncology; 2000 Aug; 59(2):110-7. PubMed ID: 10971168
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer.
Lund B; Hansen OP; Hansen HH; Hansen M
Semin Oncol; 1992 Feb; 19(1 Suppl 1):26-9. PubMed ID: 1411618
[TBL] [Abstract][Full Text] [Related]
10. Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma.
Bellmunt J; Ribas A; Eres N; Albanell J; Almanza C; Bermejo B; Solé LA; Baselga J
Cancer; 1997 Nov; 80(10):1966-72. PubMed ID: 9366300
[TBL] [Abstract][Full Text] [Related]
11. Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.
Goldman JW; Dvorkin M; Chen Y; Reinmuth N; Hotta K; Trukhin D; Statsenko G; Hochmair MJ; Özgüroğlu M; Ji JH; Garassino MC; Voitko O; Poltoratskiy A; Ponce S; Verderame F; Havel L; Bondarenko I; Każarnowicz A; Losonczy G; Conev NV; Armstrong J; Byrne N; Thiyagarajah P; Jiang H; Paz-Ares L;
Lancet Oncol; 2021 Jan; 22(1):51-65. PubMed ID: 33285097
[TBL] [Abstract][Full Text] [Related]
12. A retrospective study of definitive chemoradiotherapy in patients with resectable small cell neuroendocrine carcinoma of the esophagus.
Katada C; Komori S; Yoshida T; Kawakami S; Watanabe A; Ishido K; Azuma M; Wada T; Hosoda K; Yamashita K; Hiki N; Tanabe S; Ishiyama H; Koizumi W
Esophagus; 2020 Apr; 17(2):135-140. PubMed ID: 31321580
[TBL] [Abstract][Full Text] [Related]
13. Severe ocular and orbital toxicity after intracarotid etoposide phosphate and carboplatin therapy.
Lauer AK; Wobig JL; Shults WT; Neuwelt EA; Wilson MW
Am J Ophthalmol; 1999 Feb; 127(2):230-3. PubMed ID: 10030580
[TBL] [Abstract][Full Text] [Related]
14. Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer.
Reck M; Luft A; Szczesna A; Havel L; Kim SW; Akerley W; Pietanza MC; Wu YL; Zielinski C; Thomas M; Felip E; Gold K; Horn L; Aerts J; Nakagawa K; Lorigan P; Pieters A; Kong Sanchez T; Fairchild J; Spigel D
J Clin Oncol; 2016 Nov; 34(31):3740-3748. PubMed ID: 27458307
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study.
Bajorin DF; Sarosdy MF; Pfister DG; Mazumdar M; Motzer RJ; Scher HI; Geller NL; Fair WR; Herr H; Sogani P
J Clin Oncol; 1993 Apr; 11(4):598-606. PubMed ID: 8386751
[TBL] [Abstract][Full Text] [Related]
16. Unilateral visual impairment in a patient undergoing chemotherapy: a case report and clinical findings.
Yuan X; Feng Y; Li D; Li M
BMC Ophthalmol; 2019 Nov; 19(1):236. PubMed ID: 31752765
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support.
Elias AD; Ayash LJ; Wheeler C; Schwartz G; Tepler I; Gonin R; McCauley M; Mazanet R; Schnipper L; Frei E
Bone Marrow Transplant; 1995 Mar; 15(3):373-9. PubMed ID: 7599561
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study.
Skarlos DV; Samantas E; Kosmidis P; Fountzilas G; Angelidou M; Palamidas P; Mylonakis N; Provata A; Papadakis E; Klouvas G
Ann Oncol; 1994 Sep; 5(7):601-7. PubMed ID: 7993835
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of induction cisplatin and irinotecan followed by concurrent carboplatin, etoposide, and thoracic radiotherapy for limited-stage small-cell lung cancer, CALGB 30206.
Kelley MJ; Bogart JA; Hodgson LD; Ansari RH; Atkins JN; Pang H; Green MR; Vokes EE
J Thorac Oncol; 2013 Jan; 8(1):102-8. PubMed ID: 23196276
[TBL] [Abstract][Full Text] [Related]
20. Combined carboplatin and cisplatin. Limited prospects for dose intensification.
Waterhouse DM; Reynolds RK; Natale RB
Cancer; 1993 Jun; 71(12):4060-6. PubMed ID: 8508371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
